Search Results - Papi A

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    The efficacy of extrafine beclomethasone dipropionate–formoterol fumarate in COPD patients who are not "frequent exacerbators": a post hoc analysis of the FORWARD s... by Singh D, Vezzoli S, Petruzzelli S, Papi A

    Published in International Journal of COPD (2017-11-01)
    Get full text
    Article


  2. 2

    Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal by Vanfleteren L, Fabbri LM, Papi A, Petruzzelli S, Celli B

    Published in International Journal of COPD (2018-12-01)
    Get full text
    Article


  3. 3

    Symptom Burden, Health Status, and Productivity in Patients with Uncontrolled and Controlled Severe Asthma in NOVELTY by Ding B, Chen S, Srivastava D, Quinton A, Cook W, Papi A, Reddel HK

    Published in Journal of Asthma and Allergy (2023-06-01)
    Get full text
    Article


  4. 4

    Triple therapy in COPD: new evidence with the extrafine fixed combination of beclomethasone dipropionate, formoterol fumarate, and glycopyrronium bromide by Singh D, Corradi M, Spinola M, Papi A, Usmani OS, Scuri M, Petruzzelli S, Vestbo J

    Published in International Journal of COPD (2017-10-01)
    Get full text
    Article


  5. 5

    The Effect of Maintenance Treatment with Erdosteine on Exacerbation Treatment and Health Status in Patients with COPD: A Post-Hoc Analysis of the RESTORE Dataset by Calverley PMA, Papi A, Page C, Rogliani P, Dal Negro RW, Cazzola M, Cicero AF, Wedzicha JA

    Published in International Journal of COPD (2022-08-01)
    Get full text
    Article


  6. 6

    COPD Exacerbations Before and During COVID-19 in France, Germany, Italy, the UK and the US by Martinez FJ, Papi A, Welte T, Singh D, Galkin DV, Guasconi A, Pirondi S, Georges G, Imperato J, Hermans R

    Published in International Journal of COPD (2024-06-01)
    Get full text
    Article


  7. 7

    A Long-Term Study of Adverse Outcomes Associated With Oral Corticosteroid Use in COPD by Tse G, Emmanuel B, Ariti C, Bafadhel M, Papi A, Carter V, Zhou J, Skinner D, Xu X, Müllerová H, Price D

    Published in International Journal of COPD (2023-11-01)
    Get full text
    Article


  8. 8

    Real-World Experience with Dupilumab in Severe Asthma: One-Year Data from an Italian Named Patient Program by Campisi R, Crimi C, Nolasco S, Beghè B, Antonicelli L, Guarnieri G, Scichilone N, Porto M, Macchia L, Scioscia G, Foschino Barbaro MP, Papi A, Crimi N

    Published in Journal of Asthma and Allergy (2021-05-01)
    Get full text
    Article


  9. 9

    A Comparison of the Real-Life Clinical Effectiveness of the Leading Licensed ICS/LABA Combination Inhalers in the Treatment for COPD by Ming SWY, Haughney J, Ryan D, Small I, Lavorini F, Papi A, Singh D, Halpin DMG, Hurst JR, Patel S, Ochel M, Kocks J, Carter V, Hardjojo A, Price DB

    Published in International Journal of COPD (2020-11-01)
    Get full text
    Article


  10. 10

    Risk of Pneumonia in Patients with COPD Initiating Fixed Dose Inhaled Corticosteroid (ICS) / Long-Acting Bronchodilator (LABD) Formulations Containing Extrafine Beclometasone Dipro... by Price D, Henley W, Cançado JED, Fabbri LM, Kerstjens HA, Papi A, Roche N, Şen E, Singh D, Vogelmeier CF, Nudo E, Carter V, Skinner D, Vella R, Soriano JB, Kots M, Georges G

    Published in Pragmatic and Observational Research (2024-01-01)
    Get full text
    Article


Search Tools: